Carl Sterritt
Vorstandsvorsitzender bei Phosphate Therapeutics Ltd.
Aktive Positionen von Carl Sterritt
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Phosphate Therapeutics Ltd.
 Phosphate Therapeutics Ltd. BiotechnologyHealth Technology Phosphate Therapeutics Ltd. provides research and experimental development on biotechnology. It engages in development of drug named PT20 to cure high phosphate levels in blood. The company was founded in 2011 and is headquartered in Gateshead Quays, the United Kingdom. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Carl Sterritt
Ehemalige bekannte Positionen von Carl Sterritt
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SHIELD THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 01.01.2008 | 22.04.2020 |
| Vorstandsvorsitzender | 01.01.2008 | 22.04.2020 | |
| Gründer | 01.01.2008 | 22.04.2020 | |
| UNITED THERAPEUTICS CORPORATION | Corporate Officer/Principal | - | - |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Corporate Officer/Principal | 01.01.2006 | - |
Shield Holdings AG
 Shield Holdings AG Pharmaceuticals: MajorHealth Technology Shield Holdings AG develops and commercializes late stage pharma products. The company was founded by Carl Sterritt and Christian Schweiger in 2008 and is headquartered in Wollerau, Switzerland. | Direktor/Vorstandsmitglied | 02.06.2011 | 04.02.2015 |
| Vorstandsvorsitzender | 02.06.2011 | - | |
| Vorsitzender | - | - | |
| Gründer | 01.01.2008 | - |
Statistik
International
| Vereinigtes Königreich | 3 |
| Vereinigte Staaten | 3 |
| Schweiz | 2 |
Operativ
| Chief Executive Officer | 3 |
| Director/Board Member | 2 |
| Founder | 2 |
Sektoral
| Health Technology | 6 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| SHIELD THERAPEUTICS PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Shield Holdings AG
Shield Holdings AG Pharmaceuticals: MajorHealth Technology Shield Holdings AG develops and commercializes late stage pharma products. The company was founded by Carl Sterritt and Christian Schweiger in 2008 and is headquartered in Wollerau, Switzerland. | Health Technology |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Health Technology |
Phosphate Therapeutics Ltd.
Phosphate Therapeutics Ltd. BiotechnologyHealth Technology Phosphate Therapeutics Ltd. provides research and experimental development on biotechnology. It engages in development of drug named PT20 to cure high phosphate levels in blood. The company was founded in 2011 and is headquartered in Gateshead Quays, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Carl Sterritt
- Erfahrung
